<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Within 60 days, in response to the surge in medical need overloading medical care capacity in Wuhan, the Chinese government constructed and designated two new hospitals to care for the additional patients. In addition, reverse transcriptase polymerase chain reaction, and next-generation sequencing tests were made readily available to collect specimens of sputum, blood, stool, and bronchoalveolar lavage fluid cultures, which lead to the discovery of a novel coronavirus, SARS CoV-2, now known as COVID-19 (
 <xref rid="b0435" ref-type="bibr">Wu et al., 2020a</xref>). Evolving epidemiologic evidence determined COVID-19′s capacity to spread through human-to-human droplet transmissions, with airborne transfer under investigation (
 <xref rid="b0440" ref-type="bibr">Wu et al., 2020b</xref>). A subsequent study identified the presence of the virus in stool samples of an infected host, suggesting the potential for fecal-oral spread (
 <xref rid="b0205" ref-type="bibr">Holshue et al., 2020</xref>).
</p>
